Diabetes
Conference Coverage
High comorbidity rate seen before osteoarthritis diagnosis
More than 40 medical conditions were positively associated with having a new diagnosis of osteoarthritis in a large, nested case-control study.
Conference Coverage
Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patients
Empagliflozin showed symptomatic benefits in patients hospitalized for acute heart failure after 2 weeks in a secondary analysis from the EMPULSE...
From the Journals
‘Forever chemicals’ exposures may compound diabetes risk
The increased risk of diabetes observed among women exposed to a combination of ‘forever chemicals’ is similar to that associated with overweight...
From the Journals
Type 1 diabetes not just a childhood-onset disease
Despite popular belief that type 1 diabetes is a disease that starts in childhood, its onset in adults is substantial, researchers report.
Conference Coverage
Type 2 diabetes remission possible for those with lower BMI
Having a normal BMI is no barrier to experiencing type 2 diabetes remission with a structured weight-loss program, show U.K. results.
From the Journals
Novel tool could calculate CVD risk in T2DM
A blood pressure polygenic risk score using 1,000 genetic variants has shown the potential to calculate cardiovascular risk in people with...
Conference Coverage
New HF guidelines feature ‘quad’ therapy, tweaked terminology
They include new generalist-friendly labels for the traditional but obscurely named four stages of HF that, it is hoped, will have wider reach and...
Conference Coverage
SCORED: Sotagliflozin shows robust MACE benefit
Trial results in patients with diabetes, CKD, and high CVD risk showed robust benefits across MACE outcomes, distinguishing sotagliflozin from the...
Conference Coverage
Calcium scores predict sudden-death risk in preclinical CAD
The findings strengthen the case for initial CAC imaging as a gatekeeper to further testing in some primary-prevention patients, researchers say...
From the Journals
Be aware of gallbladder, biliary disease with newer obesity drugs
Physicians and patients should be aware of potential for gallbladder or biliary diseases with GLP-1 agonists, especially in high doses used for...
Conference Coverage
Hybrid ACC 2022 resurrects the live scientific session
The ACC offers a traditional in-person meeting spanning all of cardiology paired with what could be a lasting legacy of the pandemic, a robust,...